Opioids.

Slides:



Advertisements
Similar presentations
Pain Control in Hospice and Palliative Care
Advertisements

Opioids and other drugs we use on palliative care
Palliative Sedation Pam Mansfield, MD, CCFP October 2, 2009.
Syringe Driver Drugs.
AGS THE AMERICAN GERIATRICS SOCIETY Geriatrics Health Professionals.
Opioid Pharmacology: How to choose and how to use Romayne Gallagher MD, CCFP Division of Palliative Providence Health Care.
PAIN MANAGEMENT AT THE END OF LIFE KELLI GERSHON, FNP-BC, ACHPN SYMPTOM MANAGEMENT CONSULTANTS (SMC)
Key dosing points: Begin a bowel regimen when opioid therapy is initiated (senna + docusate). For CHRONIC pain, use a scheduled medication regimen. ( ex:
Calvin Lui, MD PGY2 February 8,  Common Opioid Agents and Good Starting Dosages  Opioid Conversion  Use of Patient Controlled Analgesia and Good.
Pain Morning Report Robin Staib, PharmD December 22, 2011.
Pain Policy Update Opioid Update Stuart Beatty, PharmD, BCPS.
Opioid Induced Neurotoxicity
UMMS CRIT Module III: Opioid Management: Considerations for Older Adults Petra Flock, MD, MSc,CMD Division of Geriatrics University of Massachusetts Medical.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 05: Relieving Pain and Providing Comfort.
A Practical Approach to Cancer Pain Management
August 16, 2015 Equianalgesia Opioid Calculator: JHH Applications Suzanne A Nesbit, PharmD, CPE Clinical Pharmacy Specialist, Pain Management Department.
Step two: Moderate pain Tramadol Opioid combinations Acetaminophen or aspirin with Codeine Hydrocodone Oxycodone Plus/minus adjuvants Dose limiting toxicity.
Plasma concentration Time PO: C max ~ 60 minutes (oxymorphone ~ 30 minutes ) SQ: C max ~ 30 minutes IV: C max ~6 minutes Pharmacologic administration curves.
 72 M, acute femoral fracture. History of hip, knee OA. Uses Tylenol, ibuprofen.  Used Norco in the past very infrequently. Keeps an old bottle in the.
C C E E N N L L E E Pediatric Palliative Care Analgesics NSAIDs  Cyclooxygenase inhibition leads to interference with production of PGs (Cox-2)  Decreased.
Pain Management in Elderly Persons Case Studies UCLA Multicampus Program of Geriatrics and Gerotontology.
Acute Pain Management Solomon Liao, M.D. Clinical Professor Director of Palliative Care Service UCI Hospitalist Program.
Using Opioids in the Hospitalized Patient Nicole Artz, MD Assistant Professor of Medicine University of Chicago No financial relationships to disclose.
Calclulation of Drug Dosages
Aging Q3 Pain Management ACOVE  Pharmacological treatment with analgesics for pain is the most common in the elderly, however, the use of alternative medications.
Treatment: other opioids Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
Development & Implementation of “Sliding Scale” Pain Protocols Jayne Pawasauskas, PharmD, BCPS Clinical Professor URI College of Pharmacy & Clinical Pharmacy.
Pain II: Cancer Pain Management Dr. Leah Steinberg.
Pain Ladder and Opiate Conversion Christopher Haigh Medicines Optimisation Pharmacist Bolton CCG.
Innovation and excellence in health and care Addenbrooke’s Hospital I Rosie Hospital FY1 Introduction to Palliative Care 7 th August 2015 Clinical Nurse.
Inadequately treated acute pain can lead to prolonged hospital stay, delayed recovery, psychological consequences, increased costs and the development.
GP Clinical Governance Meeting 13 th of July 2011 Dr Marion Lieth Consultant in Palliative Medicine, Bolton Hospital and Bolton Hospice Common issues:
Opioid Tapering Paul Coelho, MD David Tauben, MD Melissa Weimer, DO, MCR.
Opioids Tapering Melissa B. Weimer, DO, MCR. Disclosures Dr. Weimer is a consultant for INFORMed, IMPACT education, and the American Association of Addiction.
DEBBIE DONELSON, MD Opioid use for nonmalignant pain management.
PICU Analgesia & Sedation Algorithm for Endotracheally Intubated Patients Routine goal directed daily assessment. Use minimal pharmacological agents to.
Intro to Palliative Care
Potassium Repletion: IV vs. PO
Objectives Palliative pain management in the ER : Basic approach
Bone Pain: A Practical Approach to Management
Audit Opioid use in palliative patients on general hospital wards
Section III: Pharmacological Therapies
Pain and Symptom Management
Acute Pain Management Solomon Liao, M.D.
Drug Calculations Update
Palliative Care in the Outpatient Setting: Pain Management
Dr Alison Giles Palliative Medicine Consultant
Fentanyl Patch Dose Too High
Controlled drug release
Cancer Pain Management
Addressing sleep problems- The role of long-acting opioids
Opioids and other drugs we use in palliative care
Cancer Pain David Cameron
Lumbar Spinal Fusion Pain Management Pathways
Module 18 Pain Management Revised.
Pharmacokinetic–Pharmacodynamic Modeling of Opioids
EHR Tools for Acute Pain Management
Class Medication Recommendatio n Starting dose Max dose Adequate Trial
Pain Management: Patients Maintained on Buprenorphine
Erin Dale, PNP/FNP Lisa McDonough, MAS, BSN, RN
The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients  Akhila Reddy, MD, Marieberta Vidal, MD, Saneese Stephen, PA, Karen.
THE MODERN MANAGEMENT OF PAIN IN PALLIATIVE MEDICINE
OPIOID TOXICITY AND SPINAL ANALGESIA
Calculating and Using Morphine Equivalent Doses of Opioids
Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD 
Multiple ORAL Dosing Objectives
Pain Management in Palliative Care
Pain management Opioids Helen Imseeh.
Intern Bootcamp 2019: PAIN & POOOOOOOP Doug Hutcheon, MD July, 2019
Pain Management Top 10 Resident Pitfalls- 2019
Presentation transcript:

Opioids

Clinical Case 78 YO F with no PMH was admitted to the hospital for newly diagnosed pancreatic cancer. The patient has been requiring large amounts of Dilaudid (hydromorphone) IV during (totaling 8.1mg / 24 hrs). The patient is ready for discharge. What oral regimen should you send her home on?

Objective Learn some key opioid facts Learn to convert common inpatient opioids to common outpatient opioids

Key opioid Facts Renal Failure – Avoid morphine Fentanyl patches Choose: Fentanyl or Dilaudid Fentanyl patches Cachexia, body temperature, delay in onset Short vs Long Acting Dilaudid = Short only Morphine = Short or long (MS Contin) Constipation Avoid morphine in patients with renal failure or insufficiency. Morphine’s toxic metabolites are renally cleared, thus this is a bad option for these patients. Fentanyl is the best option, followed by dilauid. (People tend to not know what it looks like when people have elevated levels of toxic opioid metabolities. What you will see firs tis confusion, followed by muscular tics, then seizure/comas.) Fentanyl Patch – Absorbed via fat. Watch for placement location. Also patient’s who are cachectic may not absorb the medication at all. Will give a bolus depending on pt’s temperature (Watch in patient’s who may have fevers) Takes about 12-24 hours to have an effect on patients The only side-effect of opioids to which patients do not build a tolerance is constipation. Remember to start your patients on a bowel regimen when starting these meds

Opioid Conversion Chart IM/IV PO Morphine 10 30 Dilaudid 1.5 7.5 Fentanyl 100mcg/24h patch = 200mg PO morphine Simple conversions 1mg IV Hydromorphone = 20 mg PO morphine 1mg IV Hydromorphone = 5 mg PO hydromorphone 30mg PO Morphine = 1.5mg IV Hydromorphone ***** Please refer to a more formal chart for further conversion. I will be sticking to commonly used medications here.

Chronic Pain Opioid Conversions Total Amounts Convert Cross-Tolerance? Choose appropriate PO PRN’s/breakthrough pain Bowel regimen Tally 24 hour use of all opioids (PO and IV) Convert opioid amounts to equivocal doses of PO medication Evaluate need for cross-tolerance reduction (10-30% reduction in total dose)*see note bellow If capable of using MS Contin divide total dose of PO morphine by 2 to determine BID dose, or if only able to do shorter acting opioids (IE Oxy IR, Morphine Elixir, or PO dilaudid) divide by 6 for q4h dosing Provide PRN’s for breakthrough pain that can total 50-100% of patient’s total dose in a 24 hours period. Remember to start a bowel regimen *Cross tolerance – patient’s who are on one opioid will respond stronger to another if switched (even with equivocal dosing). For example, if someone is taking 1 mg of IV dilaudid, 20 mg of PO morphine would have a stronger response in that patient. For that reason, cross tolerance reduction of 10-30% should be done.

Clinical Follow up 8.8 mg IV Dilaudid to PO morphine = 8.8 x 20 = 176 mg PO Morphine Cross tolerance? YES! Reduce by 15% PO Morphine = 150mg MS CONTIN = BID Dosing. 150mg in BID dosing = 150/2 = 75mg MS Contin BID Breakthrough dosing = minimum of 50% total = 150 * 0.50 = 75mg / day 75mg divided into q4h dosing = 75 / 6 = ~12 mg q4h PRN Pt taking 8.8mg IV Dilaudid-> convert to PO morphine -> (20:1 ratio) equivalent to 176 mg po morphine As this pain is due to cancer, which will be a chronic pain for this patient, I will want to convert the patient to a long acting medication. I will use MS CONTIN. As I am switching from Dilaudid to morphine I will reduce dose for cross tolerance (15% reduction = ~25mg morphine) -> Thus will require ~ 150mg po morphine daily As MS CONTIN is a BID medication, 75mg MS Contin BID would be ideal dosing for this patient. Breakthrough dosing would be at least 75mg of morphine per day (50% of total day’s dose). Will divide by 6 to do q 4 hour dosing. 75/6 = 12.5 mg per dose – This can be written for as morphine elixir. Or as 15mg of Immediate Release Morphine

But that’s so many numbers! How can I keep track of all that?!

Don’t you worry little intern/resident, the internet is here to help!

Global RPH http://www.globalrph.com/narcoticonv.htm This is a great resource, but does not take the thinking out of your conversions. This, however, can help you if you don’t have an opioid conversion chart handy.

And if you have any questions… Please contact your local Palliative Care / Pain specialist.